“Statistically significant improvements in lung function, symptoms and quality of life 36% reduction in rate of exacerbations over 24 weeks Well tolerated safety profile over 48 weeks NDA submission planned for 1H 2023” Oh, 48 weeks! !

there could be a cure/preventative for breast cancer out there

They have a great product treating cancer with immunotherapy, peer reviewed journal

Alzheimer therapies are on the top of choices.

A drug that actually helps without any major side effects .. and breakthrough therapy. .

Better than chemo.

$AVXL The oral Anavex 2-73 therapy met the primary and secondary endpoints of the trial, with patients receiving the therapy experiencing statistically significant improvement in cognition.

In addition to NASH, Rencofilstat appears to be effective against Multiple Myeloma and Prostate Cancer.

but the Liver Cancer (HCC) indication and ability to treat alcohol liver disease alone make Rencofilstat a potential top tier therapeutic - on top of NASH.

This makes Rencofilstat a promising candidate for the treatment of a variety of diseases, including thromboembolic disorders, sepsis, and cancer.

This cancer stuff is very promising indeed,

It is regarded as an incredible drug that almost cures cancer.

“killed 70% – 90% of the cancer cells (4 different cell lines) over two days.

$SLRX “These initial data explain why we believe SP-3164 is so exciting, with the potential to make a positive difference in the treatment of hematologic cancers.

$SLRX SP-3164 showed significant tumor growth "inhibition" in in vivo studies including statistically significant improvement over the approved immunomodulatory drugs lenalidomide (Revlimid®) and pomalidomide (Pomalyst®)